Sun Pharma
Search results
Ranbaxy Laboratories Limited was an Indian multinational pharmaceutical company that was incorporated in India in 1961 and remained an entity until 2014. The company went public in 1973. Ownership of Ranbaxy changed twice over the course of its history.
Sun Pharma completed the acquisition of Ranbaxy Laboratories Limited, an integrated, research based, international pharmaceutical company, on 25th March 2015. Information and announcements about this can be found on this page.
Ranbaxy Laboratories Limited, India's largest pharmaceutical company, is an integrated, research based, international pharmaceutical company, producing a wide range of quality, affordable generic medicines, trusted by healthcare professionals and patients across geographies.
Ranbaxy Laboratories Limited, India's largest pharmaceutical company, is an integrated, research based, international pharmaceutical company, producing a wide range of quality, affordable generic...
Sun Pharma offers a program for individuals who want to disclose violations of US FDA requirements related to facilities owned or operated by Ranbaxy or products owned by Ranbaxy prior to Sun Pharma’s acquisition of Ranbaxy.
2 days ago · Ranbaxy Laboratories Limited Stock Price Today, Live NSE Share Price: Get the latest Ranbaxy Laboratories Limited news, company updates, quotes, tips, historical charts, 52 week high low, market performance financial reports and many more at NSE India.
Apr 1, 2015 · Ranbaxy Laboratories Ltd. is pharmaceutical company. It develops, manufactures and markets generic, branded generic, over-the-counter products, anti-retrovirals, active pharmaceutical...
Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) and Ranbaxy Laboratories Ltd (Reuters: RANB.BO, Bloomberg: RBXY IN, NSE: RANBAXY, BSE: 500359) today announced that they have entered into definitive agreements pursuant to which Sun Pharma will acquire 100% of Ranbaxy in an all-stock transaction.
Apr 7, 2014 · Dilip Shanghvi pulled off the biggest coup of his business career by hammering out an all-share deal in which his Sun Pharmaceutical will acquire struggling Gurgaon-based drugmaker Ranbaxy Laboratories, owned by Japan’s Daiichi Sankyo, for $4 billion including debt, creating what will be India’s largest drugmaker and the world’s fifth ...
Apr 7, 2014 · Sun Pharmaceutical Industries Ltd is buying Ranbaxy Laboratories Ltd through an all-stock merger in which five shares of Ranbaxy will fetch four shares of Sun Pharma. Based on their closing...
